Login to Your Account

Mission Therapeutics Gets $32M Financing for Hitting Dubs

By Cormac Sheridan
Staff Writer

Monday, November 18, 2013
Mission Therapeutics Ltd. landed £20 million (US$32 million) in second-round funding, evidence that some European investors still have a substantial appetite for preclinical biotechnology firms working in a cutting-edge area of science.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription